AUROBINDO PHARMA LTD. - Completion Of US FDA Inspection At Unit IV Of APL Healthcare Ltd
Download 
|
< Back |
| 20 Sep 2023 | |
| The USFDA inspected Unit IV, a formulation manufacturing facility of APL Healthcare Limited, a wholly owned subsidiary of the Company from September 13 to September 19, 2023. At the end of the inspection a Form 483 was issued with one observation which is procedural in nature. | |
| View all announcements for AUROBINDO PHARMA LTD. | Source: BSE India |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback